Molecular Weight:   | 308.1 |
Volume:   | 328.864 |
LogP:   | 2.847 |
LogD:   | 2.917 |
LogS:   | -3.427 |
# Rotatable Bonds:   | 6 |
TPSA:   | 74.6 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 2 |
# Rings:   | 2 |
# Heavy Atoms:   | 4 |
QED Drug-Likeness Score:   | 0.634 |
Synthetic Accessibility Score:   | 2.301 |
Fsp3:   | 0.053 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Accepted |
GSK Rule:   | Accepted |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 1 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.715 |
MDCK Permeability:   | 1.5659381460864097e-05 |
Pgp-inhibitor:   | 0.174 |
Pgp-substrate:   | 0.076 |
Human Intestinal Absorption (HIA):   | 0.017 |
20% Bioavailability (F20%):   | 0.001 |
30% Bioavailability (F30%):   | 0.008 |
Blood-Brain-Barrier Penetration (BBB):   | 0.107 |
Plasma Protein Binding (PPB):   | 99.2865219116211% |
Volume Distribution (VD):   | 0.311 |
Pgp-substrate:   | 0.5844783782958984% |
CYP1A2-inhibitor:   | 0.819 |
CYP1A2-substrate:   | 0.049 |
CYP2C19-inhibitor:   | 0.57 |
CYP2C19-substrate:   | 0.059 |
CYP2C9-inhibitor:   | 0.774 |
CYP2C9-substrate:   | 0.965 |
CYP2D6-inhibitor:   | 0.017 |
CYP2D6-substrate:   | 0.879 |
CYP3A4-inhibitor:   | 0.583 |
CYP3A4-substrate:   | 0.299 |
Clearance (CL):   | 15.98 |
Half-life (T1/2):   | 0.941 |
hERG Blockers:   | 0.23 |
Human Hepatotoxicity (H-HT):   | 0.391 |
Drug-inuced Liver Injury (DILI):   | 0.843 |
AMES Toxicity:   | 0.613 |
Rat Oral Acute Toxicity:   | 0.834 |
Maximum Recommended Daily Dose:   | 0.336 |
Skin Sensitization:   | 0.967 |
Carcinogencity:   | 0.457 |
Eye Corrosion:   | 0.01 |
Eye Irritation:   | 0.92 |
Respiratory Toxicity:   | 0.843 |
Natural Product ID:   | NPC68269 |
Common Name*:   | Bisdemethoxycurcumin |
IUPAC Name:   | (1E,6E)-1,7-bis(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione |
Synonyms:   | Bisdemethoxy Curcumin; Curcumin Lll |
Standard InCHIKey:   | PREBVFJICNPEKM-YDWXAUTNSA-N |
Standard InCHI:   | InChI=1S/C19H16O4/c20-16-7-1-14(2-8-16)5-11-18(22)13-19(23)12-6-15-3-9-17(21)10-4-15/h1-12,20-21H,13H2/b11-5+,12-6+ |
SMILES:   | c1cc(ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc(cc1)O)O |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL105350 |
PubChem CID:   |
5315472 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO22741 | Curcuma kwangsiensis | Species | Zingiberaceae | Eukaryota | n.a. | rhizome | n.a. | DOI[10.1021/np100392m] |
NPO6836 | Alpinia blepharocalyx | Species | Zingiberaceae | Eukaryota | seeds | Mengha, Yunnan Province, China | 1991-Aug |
PMID[11277741] |
NPO6836 | Alpinia blepharocalyx | Species | Zingiberaceae | Eukaryota | seeds | n.a. | n.a. |
PMID[11325233] |
NPO6836 | Alpinia blepharocalyx | Species | Zingiberaceae | Eukaryota | Seeds | n.a. | n.a. |
PMID[11430002] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[12350137] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | rhizome | n.a. | n.a. |
PMID[12617587] |
NPO5033 | Alpinia galanga | Species | Zingiberaceae | Eukaryota | rhizomes | n.a. | n.a. |
PMID[12951092] |
NPO5033 | Alpinia galanga | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[12951092] |
NPO5033 | Alpinia galanga | Species | Zingiberaceae | Eukaryota | n.a. | rhizome | n.a. |
PMID[15930771] |
NPO40808 | Daucus Carota | Species | Apiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[16180819] |
NPO22741 | Curcuma kwangsiensis | Species | Zingiberaceae | Eukaryota | Rhizomes | n.a. | n.a. |
PMID[20879743] |
NPO22741 | Curcuma kwangsiensis | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[21807513] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | Rhizomes | n.a. | n.a. |
PMID[23153397] |
NPO2618 | Curcuma wenyujin | Species | Zingiberaceae | Eukaryota | n.a. | root | n.a. |
PMID[23738470] |
NPO2618 | Curcuma wenyujin | Species | Zingiberaceae | Eukaryota | n.a. | rhizome | n.a. |
PMID[23738470] |
NPO18068 | Curcuma phaeocaulis | Species | Zingiberaceae | Eukaryota | rhizomes | n.a. | n.a. |
PMID[23755850] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | leaf | n.a. |
PMID[23901173] |
NPO2618 | Curcuma wenyujin | Species | Zingiberaceae | Eukaryota | Rhizomes | n.a. | n.a. |
PMID[25275213] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[28068085] |
NPO6836 | Alpinia blepharocalyx | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[9461664] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[9584408] |
NPO7929 | Curcuma zedoaria | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[9868158] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | Essential Oil | n.a. | n.a. | Database[FooDB] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | Leaf | n.a. | n.a. | Database[FooDB] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | Rhizome | n.a. | n.a. | Database[FooDB] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | Rhizome Essent. Oil | n.a. | n.a. | Database[FooDB] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | Root | n.a. | n.a. | Database[FooDB] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | Database[FooDB] | |
NPO9241 | Adiantum capillus-veneris | Species | Pteridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO6836 | Alpinia blepharocalyx | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO7308 | Fraxinus quadrangulata | Species | Oleaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO22741 | Curcuma kwangsiensis | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO7929 | Curcuma zedoaria | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO5033 | Alpinia galanga | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | Database[Phenol-Explorer] | |
NPO3251 | Jacobaea maritima | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO22741 | Curcuma kwangsiensis | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO7929 | Curcuma zedoaria | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO6836 | Alpinia blepharocalyx | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO9241 | Adiantum capillus-veneris | Species | Pteridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO5033 | Alpinia galanga | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO7308 | Fraxinus quadrangulata | Species | Oleaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO7929 | Curcuma zedoaria | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO9241 | Adiantum capillus-veneris | Species | Pteridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO22741 | Curcuma kwangsiensis | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO2618 | Curcuma wenyujin | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO5033 | Alpinia galanga | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO2618 | Curcuma wenyujin | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO7929 | Curcuma zedoaria | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO22741 | Curcuma kwangsiensis | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO5033 | Alpinia galanga | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO18068 | Curcuma phaeocaulis | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO5033 | Alpinia galanga | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25160 | Goniothalamus borneensis | Species | Annonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO3532 | Tridentata marginata | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[UNPD] |
NPO22741 | Curcuma kwangsiensis | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO6836 | Alpinia blepharocalyx | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO18068 | Curcuma phaeocaulis | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO24124 | Curcuma longa | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO2618 | Curcuma wenyujin | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO9241 | Adiantum capillus-veneris | Species | Pteridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO7308 | Fraxinus quadrangulata | Species | Oleaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO7929 | Curcuma zedoaria | Species | Zingiberaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO3251 | Jacobaea maritima | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPO24124 | NPC68269 | Other | Rhizome | 1403.35 | 6.7 | 2800 | mg/100g | Database [DUKE] |
NPO24124 | NPC68269 | Dried Or Powder | n.a. | 1237.5 | n.a. | n.a. | mg/100g | Database [PHENOL EXPLORER] |
NPO24124 | NPC68269 | n.a. | n.a. | 1237.5 | n.a. | n.a. | mg/100g of FW | Database [Phenol-Explorer] |
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | = | 120000.0 | nM | PMID[561350] |
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | = | 80000.0 | nM | PMID[561350] |
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | > | 100000.0 | nM | PMID[561351] |
NPT25 | Cell Line | MT4 | Homo sapiens | CC50 | = | 13000.0 | nM | PMID[561351] |
NPT91 | Cell Line | KB | Homo sapiens | CC50 | = | 8500.0 | nM | PMID[561351] |
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | = | 100000.0 | nM | PMID[561352] |
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 36370.0 | nM | PMID[561353] |
NPT324 | Individual Protein | Cyclooxygenase-1 | Ovis aries | Inhibition | = | 41.7 | % | PMID[561353] |
NPT325 | Individual Protein | Cyclooxygenase-2 | Ovis aries | Inhibition | = | 33.2 | % | PMID[561353] |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 27300.0 | nM | PMID[561356] |
NPT858 | Cell Line | LNCaP | Homo sapiens | IC50 | = | 19700.0 | nM | PMID[561356] |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 24300.0 | nM | PMID[561356] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 21900.0 | nM | PMID[561356] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | CD50 | = | 3.1 | ug ml-1 | PMID[561357] |
NPT3701 | Individual Protein | CpG DNA methylase | Spiroplasma monobiae | IC50 | = | 30.0 | nM | PMID[561360] |
NPT681 | Cell Line | PC-12 | Rattus norvegicus | ED50 | = | 2.0 | ug ml-1 | PMID[561361] |
NPT681 | Cell Line | PC-12 | Rattus norvegicus | ED50 | = | 3.5 | ug ml-1 | PMID[561361] |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 25120.0 | nM | PMID[561362] |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | > | 50000.0 | nM | PMID[561362] |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 33780.0 | nM | PMID[561362] |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | = | 30100.0 | nM | PMID[561362] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | IC50 | = | 88100.0 | nM | PMID[561362] |
NPT71 | Cell Line | HEK293 | Homo sapiens | EC50 | = | 200000.0 | nM | PMID[561364] |
NPT3704 | Individual Protein | Multidrug resistance protein CDR1 | Candida albicans | IC50 | = | 40000.0 | nM | PMID[561367] |
NPT1566 | Individual Protein | Glyoxalase I | Homo sapiens | Ki | = | 18000.0 | nM | PMID[561368] |
NPT1566 | Individual Protein | Glyoxalase I | Homo sapiens | Ki | = | 18200.0 | nM | PMID[561370] |
NPT1674 | Individual Protein | CaM kinase II alpha | Homo sapiens | IC50 | = | 37000.0 | nM | PMID[561371] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 2.0 | % | PMID[561372] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 38500.0 | nM | PMID[561373] |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 62900.0 | nM | PMID[561373] |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 38100.0 | nM | PMID[561373] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | IC50 | = | 18270.0 | nM | PMID[561374] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 24000.0 | nM | PMID[561375] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | MEC | = | 13.0 | uM | PMID[561375] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | > | 50.0 | % | PMID[561375] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 48.0 | % | PMID[561375] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 53.0 | % | PMID[561375] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 57.0 | % | PMID[561375] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | Inhibition | = | 51.0 | % | PMID[561375] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | MTC | = | 82.0 | uM | PMID[561375] |
NPT2132 | Cell Line | EOL1 | Homo sapiens | Inhibition | = | 26.0 | % | PMID[561377] |
NPT2132 | Cell Line | EOL1 | Homo sapiens | Inhibition | = | 3.0 | % | PMID[561377] |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 21440.0 | nM | PMID[561378] |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 75500.0 | nM | PMID[561383] |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Activity | = | 100.1 | % | PMID[561384] |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Activity | = | 88.8 | % | PMID[561384] |
NPT65 | Cell Line | HepG2 | Homo sapiens | Activity | = | 88.8 | % | PMID[561384] |
NPT65 | Cell Line | HepG2 | Homo sapiens | Activity | = | 69.4 | % | PMID[561384] |
NPT139 | Cell Line | HT-29 | Homo sapiens | Activity | = | 101.1 | % | PMID[561384] |
NPT139 | Cell Line | HT-29 | Homo sapiens | Activity | = | 95.4 | % | PMID[561384] |
NPT1161 | Cell Line | CHO | Cricetulus griseus | Activity | = | 101.0 | % | PMID[561385] |
NPT1161 | Cell Line | CHO | Cricetulus griseus | Activity | = | 105.0 | % | PMID[561385] |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Activity | = | 98.0 | % | PMID[561385] |
NPT492 | Cell Line | Caco-2 | Homo sapiens | Activity | = | 83.0 | % | PMID[561385] |
NPT139 | Cell Line | HT-29 | Homo sapiens | Activity | = | 75.0 | % | PMID[561385] |
NPT139 | Cell Line | HT-29 | Homo sapiens | Activity | = | 69.0 | % | PMID[561385] |
NPT1270 | Individual Protein | Aldo-keto reductase family 1 member B10 | Homo sapiens | IC50 | = | 60.0 | nM | PMID[561386] |
NPT41 | Individual Protein | Aldose reductase | Homo sapiens | IC50 | = | 5100.0 | nM | PMID[561386] |
NPT579 | Cell Line | DLD-1 | Homo sapiens | IC50 | > | 40000.0 | nM | PMID[561388] |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 48900.0 | nM | PMID[561388] |
NPT1527 | Cell Line | WRL68 | Homo sapiens | IC50 | = | 45400.0 | nM | PMID[561388] |
NPT762 | Cell Line | A-431 | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[561388] |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | Activity | = | 79.7 | % | PMID[561389] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 11000000.0 | nM | PMID[561389] |
NPT453 | Cell Line | HT-1080 | Homo sapiens | IC50 | = | 7000.0 | nM | PMID[561389] |
NPT27 | Others | Unspecified | Fold increase | = | 0.9 | n.a. | PMID[561351] | |
NPT2 | Others | Unspecified | IC50 | > | 100000.0 | nM | PMID[561355] | |
NPT35 | Others | n.a. | LogP | = | 0.85 | n.a. | PMID[561358] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Inhibition | = | 76.3 | % | PMID[561359] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Inhibition | = | 35.4 | % | PMID[561359] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Inhibition | = | 46.8 | % | PMID[561359] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Inhibition | = | 38.3 | % | PMID[561359] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 93.3 | % | PMID[561362] |
NPT471 | Organism | Trypanosoma brucei brucei | Trypanosoma brucei brucei | EC50 | = | 7700.0 | nM | PMID[561364] |
NPT471 | Organism | Trypanosoma brucei brucei | Trypanosoma brucei brucei | EC50 | = | 9500.0 | nM | PMID[561364] |
NPT471 | Organism | Trypanosoma brucei brucei | Trypanosoma brucei brucei | EC50 | = | 4500.0 | nM | PMID[561364] |
NPT841 | Organism | Leishmania major | Leishmania major | EC50 | = | 72000.0 | nM | PMID[561364] |
NPT842 | Organism | Leishmania mexicana | Leishmania mexicana | EC50 | = | 63000.0 | nM | PMID[561364] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | deltaA | = | 0.37 | n.a. | PMID[561365] |
NPT115 | Organism | Mycobacterium tuberculosis H37Ra | Mycobacterium tuberculosis H37Ra | MIC | = | 25.0 | ug.mL-1 | PMID[561366] |
NPT1 | Others | Radical scavenging activity | EC50 | > | 100000.0 | nM | PMID[561369] | |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 7.13 | % | PMID[561372] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 5.02 | U/L | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 7.13 | U/L | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 589.0 | K/uL | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 485.0 | K/uL | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 6.83 | K/uL | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 4.69 | K/uL | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 31.1 | % | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 30.6 | % | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.139 | g | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.129 | g | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 1.1 | g | PMID[561375] |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 0.987 | g | PMID[561375] |
NPT610 | Others | Molecular identity unknown | Inhibition | = | 100.3 | % | PMID[561376] | |
NPT610 | Others | Molecular identity unknown | Inhibition | = | 69.1 | % | PMID[561376] | |
NPT610 | Others | Molecular identity unknown | Inhibition | = | 77.7 | % | PMID[561376] | |
NPT610 | Others | Molecular identity unknown | Inhibition | = | 72.5 | % | PMID[561376] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 22300.0 | nM | PMID[561377] |
NPT78 | Individual Protein | Beta amyloid A4 protein | Homo sapiens | Inhibition | = | 75.0 | % | PMID[561379] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | logMIC | = | 1.0 | n.a. | PMID[561382] |
NPT35 | Others | n.a. | Solubility | = | 3180.0 | nM | PMID[561384] | |
NPT35 | Others | n.a. | Solubility | = | 4300.0 | nM | PMID[561384] | |
NPT35 | Others | n.a. | EC50 | > | 200000.0 | nM | PMID[561384] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | > | 100000.0 | nM | PMID[561384] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 91400.0 | nM | PMID[561384] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 54300.0 | nM | PMID[561384] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 104.6 | % | PMID[561384] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 107.9 | % | PMID[561384] |
NPT21728 | CELL-LINE | EA.hy 926 | Homo sapiens | Activity | = | 95.8 | % | PMID[561384] |
NPT21728 | CELL-LINE | EA.hy 926 | Homo sapiens | Activity | = | 104.6 | % | PMID[561384] |
NPT35 | Others | n.a. | Solubility | = | 25000.0 | nM | PMID[561385] | |
NPT35 | Others | n.a. | Inhibition | = | 0.02 | % | PMID[561385] | |
NPT35 | Others | n.a. | Activity | = | 0.28 | uMequiv/uM | PMID[561385] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | > | 25000.0 | nM | PMID[561385] |
NPT21728 | CELL-LINE | EA.hy 926 | Homo sapiens | Activity | = | 92.0 | % | PMID[561385] |
NPT21728 | CELL-LINE | EA.hy 926 | Homo sapiens | Activity | = | 103.0 | % | PMID[561385] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC68269 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9684 | High Similarity | NPC130193 |
0.9579 | High Similarity | NPC201967 |
0.9406 | High Similarity | NPC88141 |
0.93 | High Similarity | NPC70843 |
0.93 | High Similarity | NPC95178 |
0.93 | High Similarity | NPC29989 |
0.93 | High Similarity | NPC69332 |
0.9135 | High Similarity | NPC51698 |
0.9109 | High Similarity | NPC188677 |
0.9 | High Similarity | NPC135784 |
0.8958 | High Similarity | NPC181709 |
0.8942 | High Similarity | NPC222905 |
0.8942 | High Similarity | NPC116842 |
0.8911 | High Similarity | NPC120693 |
0.8911 | High Similarity | NPC261573 |
0.8911 | High Similarity | NPC8931 |
0.89 | High Similarity | NPC472585 |
0.8785 | High Similarity | NPC285350 |
0.8762 | High Similarity | NPC21162 |
0.875 | High Similarity | NPC17525 |
0.8704 | High Similarity | NPC23402 |
0.8679 | High Similarity | NPC297657 |
0.8673 | High Similarity | NPC32977 |
0.8673 | High Similarity | NPC81010 |
0.8673 | High Similarity | NPC151715 |
0.8654 | High Similarity | NPC260952 |
0.8624 | High Similarity | NPC277394 |
0.8624 | High Similarity | NPC299252 |
0.8624 | High Similarity | NPC61062 |
0.8586 | High Similarity | NPC26244 |
0.8586 | High Similarity | NPC286006 |
0.8585 | High Similarity | NPC183700 |
0.8532 | High Similarity | NPC322197 |
0.8505 | High Similarity | NPC177576 |
0.8505 | High Similarity | NPC268388 |
0.85 | High Similarity | NPC132271 |
0.85 | High Similarity | NPC292730 |
0.85 | High Similarity | NPC473388 |
0.85 | High Similarity | NPC216520 |
0.85 | High Similarity | NPC82664 |
0.8476 | Intermediate Similarity | NPC141523 |
0.8469 | Intermediate Similarity | NPC45040 |
0.8455 | Intermediate Similarity | NPC19290 |
0.8416 | Intermediate Similarity | NPC260000 |
0.8411 | Intermediate Similarity | NPC321252 |
0.8411 | Intermediate Similarity | NPC252544 |
0.8396 | Intermediate Similarity | NPC206341 |
0.8381 | Intermediate Similarity | NPC6984 |
0.835 | Intermediate Similarity | NPC40258 |
0.835 | Intermediate Similarity | NPC91461 |
0.835 | Intermediate Similarity | NPC7686 |
0.8333 | Intermediate Similarity | NPC51333 |
0.8333 | Intermediate Similarity | NPC216468 |
0.8333 | Intermediate Similarity | NPC78119 |
0.8333 | Intermediate Similarity | NPC132078 |
0.8333 | Intermediate Similarity | NPC280869 |
0.8333 | Intermediate Similarity | NPC470355 |
0.8318 | Intermediate Similarity | NPC95172 |
0.8318 | Intermediate Similarity | NPC79543 |
0.8316 | Intermediate Similarity | NPC265146 |
0.8304 | Intermediate Similarity | NPC249435 |
0.8302 | Intermediate Similarity | NPC226699 |
0.83 | Intermediate Similarity | NPC128062 |
0.8283 | Intermediate Similarity | NPC270547 |
0.8265 | Intermediate Similarity | NPC280347 |
0.8265 | Intermediate Similarity | NPC177420 |
0.8265 | Intermediate Similarity | NPC98772 |
0.8257 | Intermediate Similarity | NPC228988 |
0.8257 | Intermediate Similarity | NPC286222 |
0.8252 | Intermediate Similarity | NPC253746 |
0.8252 | Intermediate Similarity | NPC213730 |
0.8247 | Intermediate Similarity | NPC184169 |
0.8235 | Intermediate Similarity | NPC140619 |
0.8229 | Intermediate Similarity | NPC248817 |
0.8229 | Intermediate Similarity | NPC175313 |
0.8218 | Intermediate Similarity | NPC257182 |
0.8218 | Intermediate Similarity | NPC246679 |
0.8218 | Intermediate Similarity | NPC274678 |
0.819 | Intermediate Similarity | NPC160900 |
0.819 | Intermediate Similarity | NPC52087 |
0.819 | Intermediate Similarity | NPC18984 |
0.819 | Intermediate Similarity | NPC79672 |
0.819 | Intermediate Similarity | NPC106659 |
0.819 | Intermediate Similarity | NPC229084 |
0.8182 | Intermediate Similarity | NPC55561 |
0.8163 | Intermediate Similarity | NPC25493 |
0.8163 | Intermediate Similarity | NPC113460 |
0.8163 | Intermediate Similarity | NPC104216 |
0.8155 | Intermediate Similarity | NPC245561 |
0.8155 | Intermediate Similarity | NPC92730 |
0.8144 | Intermediate Similarity | NPC197783 |
0.8137 | Intermediate Similarity | NPC283711 |
0.8125 | Intermediate Similarity | NPC124436 |
0.8125 | Intermediate Similarity | NPC28951 |
0.8125 | Intermediate Similarity | NPC128249 |
0.8125 | Intermediate Similarity | NPC325646 |
0.8119 | Intermediate Similarity | NPC76938 |
0.8113 | Intermediate Similarity | NPC303141 |
0.8113 | Intermediate Similarity | NPC243677 |
0.8113 | Intermediate Similarity | NPC13495 |
0.8113 | Intermediate Similarity | NPC127676 |
0.8103 | Intermediate Similarity | NPC68167 |
0.8103 | Intermediate Similarity | NPC86900 |
0.8095 | Intermediate Similarity | NPC168829 |
0.8095 | Intermediate Similarity | NPC470202 |
0.8095 | Intermediate Similarity | NPC304638 |
0.8081 | Intermediate Similarity | NPC123273 |
0.8081 | Intermediate Similarity | NPC318325 |
0.8081 | Intermediate Similarity | NPC242240 |
0.8077 | Intermediate Similarity | NPC52472 |
0.8077 | Intermediate Similarity | NPC223393 |
0.8073 | Intermediate Similarity | NPC63345 |
0.807 | Intermediate Similarity | NPC158222 |
0.8061 | Intermediate Similarity | NPC23167 |
0.8058 | Intermediate Similarity | NPC225464 |
0.8056 | Intermediate Similarity | NPC317305 |
0.8039 | Intermediate Similarity | NPC32714 |
0.8037 | Intermediate Similarity | NPC1786 |
0.8037 | Intermediate Similarity | NPC294902 |
0.8037 | Intermediate Similarity | NPC1075 |
0.8019 | Intermediate Similarity | NPC288411 |
0.8018 | Intermediate Similarity | NPC242136 |
0.8017 | Intermediate Similarity | NPC196976 |
0.8 | Intermediate Similarity | NPC114682 |
0.8 | Intermediate Similarity | NPC473136 |
0.8 | Intermediate Similarity | NPC159525 |
0.8 | Intermediate Similarity | NPC212718 |
0.8 | Intermediate Similarity | NPC228609 |
0.8 | Intermediate Similarity | NPC300017 |
0.7982 | Intermediate Similarity | NPC471033 |
0.7982 | Intermediate Similarity | NPC311091 |
0.7981 | Intermediate Similarity | NPC275104 |
0.7963 | Intermediate Similarity | NPC34715 |
0.7963 | Intermediate Similarity | NPC228737 |
0.7944 | Intermediate Similarity | NPC138942 |
0.7944 | Intermediate Similarity | NPC233396 |
0.7944 | Intermediate Similarity | NPC154899 |
0.7944 | Intermediate Similarity | NPC219913 |
0.7944 | Intermediate Similarity | NPC474839 |
0.7931 | Intermediate Similarity | NPC60962 |
0.7931 | Intermediate Similarity | NPC14007 |
0.7931 | Intermediate Similarity | NPC269843 |
0.7931 | Intermediate Similarity | NPC236520 |
0.7931 | Intermediate Similarity | NPC109083 |
0.7931 | Intermediate Similarity | NPC224814 |
0.7931 | Intermediate Similarity | NPC294361 |
0.7931 | Intermediate Similarity | NPC248363 |
0.7931 | Intermediate Similarity | NPC189844 |
0.7928 | Intermediate Similarity | NPC231717 |
0.7913 | Intermediate Similarity | NPC141791 |
0.7913 | Intermediate Similarity | NPC263386 |
0.7913 | Intermediate Similarity | NPC182240 |
0.7913 | Intermediate Similarity | NPC264976 |
0.7909 | Intermediate Similarity | NPC208229 |
0.7909 | Intermediate Similarity | NPC471535 |
0.7905 | Intermediate Similarity | NPC248573 |
0.7905 | Intermediate Similarity | NPC294741 |
0.7905 | Intermediate Similarity | NPC275053 |
0.7905 | Intermediate Similarity | NPC161571 |
0.79 | Intermediate Similarity | NPC258219 |
0.7899 | Intermediate Similarity | NPC197832 |
0.7895 | Intermediate Similarity | NPC185738 |
0.7895 | Intermediate Similarity | NPC280001 |
0.7895 | Intermediate Similarity | NPC278652 |
0.789 | Intermediate Similarity | NPC470039 |
0.789 | Intermediate Similarity | NPC68260 |
0.789 | Intermediate Similarity | NPC31274 |
0.789 | Intermediate Similarity | NPC224584 |
0.789 | Intermediate Similarity | NPC279887 |
0.7885 | Intermediate Similarity | NPC32674 |
0.7881 | Intermediate Similarity | NPC306100 |
0.7881 | Intermediate Similarity | NPC285345 |
0.7876 | Intermediate Similarity | NPC296526 |
0.787 | Intermediate Similarity | NPC113457 |
0.787 | Intermediate Similarity | NPC92623 |
0.787 | Intermediate Similarity | NPC135464 |
0.787 | Intermediate Similarity | NPC19149 |
0.7863 | Intermediate Similarity | NPC115159 |
0.7863 | Intermediate Similarity | NPC267552 |
0.7863 | Intermediate Similarity | NPC45438 |
0.7863 | Intermediate Similarity | NPC73532 |
0.7863 | Intermediate Similarity | NPC19174 |
0.7863 | Intermediate Similarity | NPC224273 |
0.7863 | Intermediate Similarity | NPC143427 |
0.7857 | Intermediate Similarity | NPC11824 |
0.7851 | Intermediate Similarity | NPC221777 |
0.785 | Intermediate Similarity | NPC93831 |
0.785 | Intermediate Similarity | NPC119860 |
0.785 | Intermediate Similarity | NPC323810 |
0.785 | Intermediate Similarity | NPC471511 |
0.7845 | Intermediate Similarity | NPC265454 |
0.7845 | Intermediate Similarity | NPC34634 |
0.7843 | Intermediate Similarity | NPC138117 |
0.7843 | Intermediate Similarity | NPC325292 |
0.7843 | Intermediate Similarity | NPC271440 |
0.7838 | Intermediate Similarity | NPC139946 |
0.7833 | Intermediate Similarity | NPC276014 |
0.783 | Intermediate Similarity | NPC94343 |
0.7826 | Intermediate Similarity | NPC184527 |
0.7826 | Intermediate Similarity | NPC275519 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC68269 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8673 | High Similarity | NPD2934 | Approved |
0.8673 | High Similarity | NPD2933 | Approved |
0.8586 | High Similarity | NPD2859 | Approved |
0.8586 | High Similarity | NPD2860 | Approved |
0.8333 | Intermediate Similarity | NPD3020 | Approved |
0.819 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.8125 | Intermediate Similarity | NPD111 | Approved |
0.7905 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7895 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7818 | Intermediate Similarity | NPD3021 | Approved |
0.7818 | Intermediate Similarity | NPD3022 | Approved |
0.7798 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7767 | Intermediate Similarity | NPD1432 | Clinical (unspecified phase) |
0.7736 | Intermediate Similarity | NPD3028 | Approved |
0.7542 | Intermediate Similarity | NPD3019 | Approved |
0.7542 | Intermediate Similarity | NPD2932 | Approved |
0.75 | Intermediate Similarity | NPD940 | Approved |
0.75 | Intermediate Similarity | NPD846 | Approved |
0.7458 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7411 | Intermediate Similarity | NPD74 | Approved |
0.7411 | Intermediate Similarity | NPD9266 | Approved |
0.7387 | Intermediate Similarity | NPD3134 | Approved |
0.7373 | Intermediate Similarity | NPD9545 | Approved |
0.7364 | Intermediate Similarity | NPD1237 | Approved |
0.7358 | Intermediate Similarity | NPD844 | Approved |
0.7358 | Intermediate Similarity | NPD1809 | Phase 2 |
0.7355 | Intermediate Similarity | NPD3972 | Approved |
0.735 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD845 | Approved |
0.7333 | Intermediate Similarity | NPD3847 | Discontinued |
0.7321 | Intermediate Similarity | NPD9264 | Approved |
0.7321 | Intermediate Similarity | NPD9263 | Approved |
0.7321 | Intermediate Similarity | NPD9267 | Approved |
0.7321 | Intermediate Similarity | NPD1358 | Approved |
0.7317 | Intermediate Similarity | NPD1164 | Approved |
0.7317 | Intermediate Similarity | NPD1470 | Approved |
0.7302 | Intermediate Similarity | NPD3764 | Approved |
0.7273 | Intermediate Similarity | NPD1201 | Approved |
0.7273 | Intermediate Similarity | NPD1535 | Discovery |
0.7241 | Intermediate Similarity | NPD2229 | Approved |
0.7241 | Intermediate Similarity | NPD2234 | Approved |
0.7241 | Intermediate Similarity | NPD1241 | Discontinued |
0.7241 | Intermediate Similarity | NPD2228 | Approved |
0.7232 | Intermediate Similarity | NPD968 | Approved |
0.7213 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7203 | Intermediate Similarity | NPD9493 | Approved |
0.7188 | Intermediate Similarity | NPD943 | Approved |
0.7177 | Intermediate Similarity | NPD1203 | Approved |
0.717 | Intermediate Similarity | NPD1202 | Approved |
0.7158 | Intermediate Similarity | NPD9087 | Approved |
0.7155 | Intermediate Similarity | NPD5535 | Approved |
0.713 | Intermediate Similarity | NPD288 | Approved |
0.7119 | Intermediate Similarity | NPD255 | Approved |
0.7119 | Intermediate Similarity | NPD256 | Approved |
0.7097 | Intermediate Similarity | NPD1876 | Approved |
0.7097 | Intermediate Similarity | NPD3225 | Approved |
0.7091 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD1894 | Discontinued |
0.7059 | Intermediate Similarity | NPD9568 | Approved |
0.7054 | Intermediate Similarity | NPD1240 | Approved |
0.7054 | Intermediate Similarity | NPD9610 | Approved |
0.7054 | Intermediate Similarity | NPD9608 | Approved |
0.7049 | Intermediate Similarity | NPD3023 | Approved |
0.7049 | Intermediate Similarity | NPD3026 | Approved |
0.7048 | Intermediate Similarity | NPD9256 | Approved |
0.7048 | Intermediate Similarity | NPD9258 | Approved |
0.7045 | Intermediate Similarity | NPD2935 | Discontinued |
0.7041 | Intermediate Similarity | NPD9088 | Approved |
0.704 | Intermediate Similarity | NPD2797 | Approved |
0.7034 | Intermediate Similarity | NPD9281 | Approved |
0.7031 | Intermediate Similarity | NPD3268 | Approved |
0.7025 | Intermediate Similarity | NPD3024 | Approved |
0.7025 | Intermediate Similarity | NPD3025 | Approved |
0.7018 | Intermediate Similarity | NPD2342 | Discontinued |
0.7009 | Intermediate Similarity | NPD7635 | Approved |
0.7 | Intermediate Similarity | NPD2066 | Phase 3 |
0.6992 | Remote Similarity | NPD2344 | Approved |
0.6984 | Remote Similarity | NPD2798 | Approved |
0.697 | Remote Similarity | NPD3299 | Clinical (unspecified phase) |
0.697 | Remote Similarity | NPD2799 | Discontinued |
0.697 | Remote Similarity | NPD1510 | Phase 2 |
0.6967 | Remote Similarity | NPD5238 | Clinical (unspecified phase) |
0.6964 | Remote Similarity | NPD9261 | Approved |
0.6957 | Remote Similarity | NPD6831 | Clinical (unspecified phase) |
0.6947 | Remote Similarity | NPD1607 | Approved |
0.6942 | Remote Similarity | NPD1759 | Phase 1 |
0.6942 | Remote Similarity | NPD5303 | Approved |
0.6942 | Remote Similarity | NPD5304 | Approved |
0.6942 | Remote Similarity | NPD3091 | Approved |
0.6929 | Remote Similarity | NPD4208 | Discontinued |
0.6929 | Remote Similarity | NPD5736 | Approved |
0.6923 | Remote Similarity | NPD6124 | Clinical (unspecified phase) |
0.6917 | Remote Similarity | NPD5406 | Approved |
0.6917 | Remote Similarity | NPD5408 | Approved |
0.6917 | Remote Similarity | NPD5405 | Approved |
0.6917 | Remote Similarity | NPD5404 | Approved |
0.6911 | Remote Similarity | NPD3421 | Phase 3 |
0.6909 | Remote Similarity | NPD9273 | Approved |
0.6897 | Remote Similarity | NPD5451 | Approved |
0.6897 | Remote Similarity | NPD1792 | Phase 2 |
0.6897 | Remote Similarity | NPD4750 | Phase 3 |
0.6897 | Remote Similarity | NPD9380 | Clinical (unspecified phase) |
0.6889 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6885 | Remote Similarity | NPD4093 | Discontinued |
0.6885 | Remote Similarity | NPD1651 | Approved |
0.688 | Remote Similarity | NPD3600 | Clinical (unspecified phase) |
0.686 | Remote Similarity | NPD1758 | Phase 1 |
0.6855 | Remote Similarity | NPD422 | Phase 1 |
0.6852 | Remote Similarity | NPD5122 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD1509 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD9697 | Approved |
0.6838 | Remote Similarity | NPD3750 | Approved |
0.6838 | Remote Similarity | NPD8166 | Discontinued |
0.6829 | Remote Similarity | NPD4589 | Approved |
0.6829 | Remote Similarity | NPD2286 | Discontinued |
0.6829 | Remote Similarity | NPD4059 | Approved |
0.6829 | Remote Similarity | NPD4626 | Approved |
0.6822 | Remote Similarity | NPD7095 | Approved |
0.6815 | Remote Similarity | NPD1549 | Phase 2 |
0.6814 | Remote Similarity | NPD1931 | Clinical (unspecified phase) |
0.6814 | Remote Similarity | NPD1930 | Approved |
0.6814 | Remote Similarity | NPD6647 | Phase 2 |
0.6814 | Remote Similarity | NPD1929 | Approved |
0.681 | Remote Similarity | NPD2684 | Approved |
0.6807 | Remote Similarity | NPD7159 | Clinical (unspecified phase) |
0.6807 | Remote Similarity | NPD5283 | Phase 1 |
0.6803 | Remote Similarity | NPD1548 | Phase 1 |
0.68 | Remote Similarity | NPD2562 | Approved |
0.68 | Remote Similarity | NPD9717 | Approved |
0.68 | Remote Similarity | NPD2561 | Approved |
0.68 | Remote Similarity | NPD9269 | Phase 2 |
0.6797 | Remote Similarity | NPD9494 | Approved |
0.6788 | Remote Similarity | NPD2309 | Approved |
0.6788 | Remote Similarity | NPD6190 | Approved |
0.6783 | Remote Similarity | NPD1444 | Approved |
0.6783 | Remote Similarity | NPD1445 | Approved |
0.678 | Remote Similarity | NPD228 | Approved |
0.6772 | Remote Similarity | NPD4339 | Clinical (unspecified phase) |
0.6769 | Remote Similarity | NPD6859 | Clinical (unspecified phase) |
0.6769 | Remote Similarity | NPD6798 | Discontinued |
0.6769 | Remote Similarity | NPD2313 | Discontinued |
0.6768 | Remote Similarity | NPD9294 | Approved |
0.6765 | Remote Similarity | NPD9089 | Approved |
0.6754 | Remote Similarity | NPD5909 | Discontinued |
0.675 | Remote Similarity | NPD1476 | Clinical (unspecified phase) |
0.675 | Remote Similarity | NPD5951 | Approved |
0.6748 | Remote Similarity | NPD9268 | Approved |
0.6746 | Remote Similarity | NPD6583 | Phase 3 |
0.6746 | Remote Similarity | NPD1755 | Approved |
0.6746 | Remote Similarity | NPD4659 | Approved |
0.6746 | Remote Similarity | NPD6582 | Phase 2 |
0.6744 | Remote Similarity | NPD2614 | Approved |
0.6744 | Remote Similarity | NPD4207 | Discontinued |
0.6741 | Remote Similarity | NPD1550 | Clinical (unspecified phase) |
0.6741 | Remote Similarity | NPD7266 | Discontinued |
0.6741 | Remote Similarity | NPD1552 | Clinical (unspecified phase) |
0.6735 | Remote Similarity | NPD9716 | Approved |
0.6723 | Remote Similarity | NPD9377 | Approved |
0.6723 | Remote Similarity | NPD9379 | Approved |
0.6723 | Remote Similarity | NPD7843 | Approved |
0.672 | Remote Similarity | NPD1547 | Clinical (unspecified phase) |
0.672 | Remote Similarity | NPD3092 | Approved |
0.6719 | Remote Similarity | NPD7451 | Discontinued |
0.6718 | Remote Similarity | NPD4062 | Phase 3 |
0.6718 | Remote Similarity | NPD6233 | Phase 2 |
0.6718 | Remote Similarity | NPD6663 | Approved |
0.6716 | Remote Similarity | NPD6866 | Clinical (unspecified phase) |
0.6716 | Remote Similarity | NPD6867 | Clinical (unspecified phase) |
0.6715 | Remote Similarity | NPD4628 | Phase 3 |
0.6699 | Remote Similarity | NPD3971 | Phase 1 |
0.6696 | Remote Similarity | NPD1238 | Approved |
0.6695 | Remote Similarity | NPD9280 | Clinical (unspecified phase) |
0.6694 | Remote Similarity | NPD6671 | Approved |
0.6694 | Remote Similarity | NPD3095 | Discontinued |
0.6693 | Remote Similarity | NPD5311 | Approved |
0.6693 | Remote Similarity | NPD5310 | Approved |
0.6693 | Remote Similarity | NPD1283 | Approved |
0.6692 | Remote Similarity | NPD3136 | Phase 2 |
0.6667 | Remote Similarity | NPD4060 | Phase 1 |
0.6667 | Remote Similarity | NPD7450 | Phase 2 |
0.6667 | Remote Similarity | NPD9257 | Approved |
0.6667 | Remote Similarity | NPD9500 | Approved |
0.6667 | Remote Similarity | NPD4878 | Approved |
0.6667 | Remote Similarity | NPD9259 | Approved |
0.6667 | Remote Similarity | NPD2337 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD9093 | Approved |
0.6643 | Remote Similarity | NPD7410 | Clinical (unspecified phase) |
0.6643 | Remote Similarity | NPD4378 | Clinical (unspecified phase) |
0.6641 | Remote Similarity | NPD3267 | Approved |
0.6641 | Remote Similarity | NPD4103 | Phase 2 |
0.6641 | Remote Similarity | NPD3055 | Approved |
0.6641 | Remote Similarity | NPD3266 | Approved |
0.6641 | Remote Similarity | NPD4104 | Clinical (unspecified phase) |
0.6641 | Remote Similarity | NPD3094 | Phase 2 |
0.6641 | Remote Similarity | NPD3053 | Approved |
0.664 | Remote Similarity | NPD3496 | Discontinued |
0.6639 | Remote Similarity | NPD7325 | Clinical (unspecified phase) |
0.6619 | Remote Similarity | NPD7440 | Discontinued |
0.6617 | Remote Similarity | NPD6355 | Discontinued |
0.6617 | Remote Similarity | NPD4340 | Discontinued |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.